Position history for NATIXIS's holdings in ABBOTT LABORATORIES
NATIXIS holds 778,903 shares of ABT (ABBOTT LABORATORIES), worth $80M as of 2026-Q1. The position was increased (+171.0% shares). ABT represents 0.3% of NATIXIS's portfolio.
Current Value
$80M
Current Shares
778,903
Total Value Change
+$25.7M
Total Shares Change
+256,858
Other major holders of ABT: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 778,903 |
+171.0% |
| $80M |
| 0.3% |
| $113.61 |
57 |
| 2025-Q4 | Decreased | 287,397 | -57.1% | $36M | 0.1% | $125.15 | 0 |
| 2025-Q3 | Increased | 670,055 | +96.4% | $89.7M | 0.4% | $131.85 | 57 |
| 2025-Q2 | Decreased | 341,127 | -15.6% | $46.4M | 0.2% | $132.52 | 0 |
| 2025-Q1 | Increased | 404,271 | +35.1% | $53.5M | 0.3% | $128.41 | 45 |
| 2024-Q4 | Decreased | 299,275 | -26.9% | $33.9M | 0.2% | $110.14 | 0 |
| 2024-Q3 | Decreased | 409,539 | -21.6% | $46.7M | 0.3% | $109.27 | 0 |
| 2024-Q2 | Increased | 522,045 | +146.1% | $54.2M | 0.3% | $100.45 | 57 |